Literature DB >> 23296554

[Kiva® VCF Treatment System - clinical study on the efficacy and patient safety of a new system for augmentation of vertebral compression fractures].

R Bornemann1, L A Otten, E M W Koch, T R Jansen, K Kabir, D C Wirtz, R Pflugmacher.   

Abstract

BACKGROUND: As a further alternative to previously used vertebral augmentation methods, the Kiva VCF Treatment System® was clinically investigated.
MATERIAL AND METHODS: The pilot study included 24 patients (mean age 74 years, 34 vertebrae).
RESULTS: During an operation period of 16.6 minutes on average 2.2 ± 1 mL of PMMA cement were injected. 87 % of patients were satisfied or very satisfied with this treatment. In 2 cases leakage of cement has been registered. The pain intensity was already reduced after 7 days to 69.5 mm (VAS scale 0-100). After 30 days, the difference from baseline was 76 mm. Significant improvements have also been shown in the Oswestry Score (functional ability), physical performance and mental well-being.
CONCLUSION: On the basis of these results, the new augmentation can be described as being effective in the treatment of painful vertebral fractures. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296554     DOI: 10.1055/s-0032-1327935

Source DB:  PubMed          Journal:  Z Orthop Unfall        ISSN: 1864-6697            Impact factor:   0.923


  2 in total

1.  KIVA VCF system in the treatment of T12 osteoporotic vertebral compression fracture.

Authors:  Pedro Berjano; Marco Damilano; Matteo Pejrona; Olmo Consonni; Francesco Langella; Claudio Lamartina
Journal:  Eur Spine J       Date:  2014-06       Impact factor: 3.134

Review 2.  Advances in Vertebral Augmentation Systems for Osteoporotic Vertebral Compression Fractures.

Authors:  Yufeng Long; Weihong Yi; Dazhi Yang
Journal:  Pain Res Manag       Date:  2020-12-07       Impact factor: 3.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.